Galectin Therapeutics (GALT) Other Accumulated Expenses (2011 - 2015)

Galectin Therapeutics' Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $6000.0 for Q3 2015.

• In Q3 2015, Other Accumulated Expenses rose 200.0% year-over-year to $6000.0; the TTM figure through Sep 2015 stood at $6000.0 (up 200.0% YoY), while the FY2014 annual figure was $7000.0, down 68.18% from the prior year.
• Other Accumulated Expenses for Q3 2015 stood at $6000.0, down from $7000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $98000.0 in Q1 2014, with the low at $2000.0 in Q2 2014.
• The 5-year median for Other Accumulated Expenses is $10000.0 (2012), against an average of $29800.0.
• Peak annual rise in Other Accumulated Expenses reached 790.91% in 2014, while the deepest fall reached 96.3% in 2014.
• Galectin Therapeutics' Other Accumulated Expenses stood at $97000.0 in 2011, then sank by 89.69% to $10000.0 in 2012, then jumped by 120.0% to $22000.0 in 2013, then slumped by 68.18% to $7000.0 in 2014, then decreased by 14.29% to $6000.0 in 2015.
• Business Quant data shows GALT's Other Accumulated Expenses at $6000.0 in Q3 2015, $7000.0 in Q2 2015, and $72000.0 in Q1 2015.